Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
41.00
Ask:
44.00
Spread: 3.00 (7.317%)
Market Cap: £10.13m
SWG Live PriceLast checked at - London Stock Exchange

Intraday Shearwater Share Chart

Holding(s) in Company

30 Jan 2009 12:09

RNS Number : 5455M
Scott Wilson Group plc
30 January 2009
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Scott Wilson Group plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

Aviva plc & its subsidiaries

4. Full name of shareholder(s) (if different from 3):

Registered Holder:

BNY Norwich Union Nominees Limited 435,498*

Chase GA Group Nominees Limited 1,485,630*

Chase Nominees Limited 135,800*

CUIM Nominee Limited 296,080*

* denotes direct interest

5. Date of transaction (and date on which the threshold is crossed or reached if different):

28 January 2009

6. Date on which issuer notified:

29 January 2009

7. Threshold(s) that is/are crossed or reached:

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

Ordinary Shares

GB00B0WM2V87

Below 3%

Below 3%

2,353,008

2,353,008

Not disclosable

3.13%

Not disclosable

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

Total (A+B)

Number of voting rights

Percentage of voting rights

2,353,008

3.13%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

Aviva Investors Global Services Limited:

* Aviva plc (parent company)

* Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

* Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

* Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

Proxy Voting:

10. Name of proxy holder:

See section 4

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Figures are based on a total number of voting rights of 75,175,446

14 Contact name:

G M Redwood

Company Secretary

15. Contact telephone number:

Tel: 01256 310225

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAAFEDEPNEFE
Date   Source Headline
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update
8th Jun 20237:00 amRNSTrading Update
5th May 20232:33 pmRNSHolding(s) in Company
18th Apr 20238:58 amRNSDirector/PDMR Shareholding
17th Apr 202312:51 pmRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSTrading Update
8th Mar 20233:30 pmRNSHolding(s) in Company
28th Feb 20231:26 pmRNSExercise of Options
8th Dec 20222:34 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20222:40 pmRNSDirector/PDMR Shareholding
29th Nov 20222:05 pmRNSSecond Price Monitoring Extn
29th Nov 20222:00 pmRNSPrice Monitoring Extension
29th Nov 20227:00 amRNSResults for the six months ended 30 September 2022
23rd Nov 20227:00 amRNSAdviser Update
17th Nov 20227:00 amRNSNotice of Results and Presentation to Investors
7th Oct 20228:32 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSResult of AGM
5th Sep 202210:00 amRNSNotice of AGM
1st Sep 20227:00 amRNSContract Renewal
25th Aug 20227:00 amRNSPosting of Annual Report
23rd Aug 20222:43 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSFinal Results
22nd Jul 20227:00 amRNSNotice of Results and Presentation to Investors
6th Jun 20224:41 pmRNSSecond Price Monitoring Extn
6th Jun 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSYear End Trading Update
13th Apr 20227:00 amRNSContract Win
24th Mar 20227:00 amRNSContract Win
22nd Mar 20224:37 pmRNSExercise of options
17th Mar 20227:00 amRNSContract Win
3rd Mar 20224:26 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSGrant of Options and Director/PDMR Dealing
27th Jan 20227:00 amRNSContract Renewals
11th Jan 20227:00 amRNSContract Win
14th Dec 20217:00 amRNSDirector/PDMR Shareholding
9th Dec 202112:49 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
16th Nov 20217:00 amRNSNotice of Results and Presentation to Investors
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20212:55 pmRNSResult of AGM
15th Sep 20217:00 amRNSContract Renewal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.